(Q33699343)

28 July 2017

1 reference

title

Magnetic resonance spectroscopy: imaging axonal damage in MS. (English)

1 reference

28 July 2017

Arnold DL

1

1 reference

28 July 2017

publication date

1 July 1999

1 reference

Journal of Neuroimmunology

28 July 2017

published in

1 reference

28 July 2017

volume

98

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

2-6

1 reference

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

The longstanding MS lesion. A quantitative MRI and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

Diabetes and exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900074-0

7 January 2021

10.1016/S0165-5728(99)00074-0

Identifiers

DOI

1 reference

28 July 2017

1 reference